Follow

"So the foundations of the entire Cassava Alzheimer's program are shaky. And as you'll see from this, that's not the end of it. Thirty-four papers by Cassava-associated scientists have come under scrutiny for research irregularities, and this led to a petition filing to the FDA asking that the company be investigated and their clinical trials halted."

science.org/content/blog-post/

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.